[1]
Liester, M.B. et al. 2026. The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity. Journal of Neurology Research. 16, 3 (Jan. 2026), 127–140. DOI:https://doi.org/10.14740/jnr1115.